Mirela Mihart, Veronica Mercuț, Sanda Mihaela Popescu, Monica Mihaela Iacov-Crăițoiu, Mihaela Ionescu, Adina Dorina Glodeanu, Alexandra Maria Rădoi, Monica Scrieciu
{"title":"The Number of Remaining Teeth-A Predictability Factor for a Certain Type of Cardiovascular Condition in a Group of Hospitalized Individuals.","authors":"Mirela Mihart, Veronica Mercuț, Sanda Mihaela Popescu, Monica Mihaela Iacov-Crăițoiu, Mihaela Ionescu, Adina Dorina Glodeanu, Alexandra Maria Rădoi, Monica Scrieciu","doi":"10.3390/jpm14121166","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The aim of this study was to determine whether the oral parameter reflecting the total number of remaining permanent teeth (NRT) on both arches represents a predictability factor for a certain type of cardiovascular condition. <b>Methods</b>: This study included 84 subjects (40 males and 44 females) with ages between 50 and 89 years old, hospitalized in the Cardiology Department, who required dental examinations and specialized therapeutic interventions within the Emergency Dental Department of the same medical facility. <b>Results</b>: The study participant's data were statically analyzed. An unadjusted oral parameter NRT < 21 may represent a statistically significant predictor of developing cardiomyopathy (OR = 8.00, 95%CI = 2.78-23.06, <i>p</i> < 0.0005), heart valve disease and arterial hypertension, in association with other comorbidities (except for metabolic or pulmonary comorbidities). The regression analyses revealed a borderline-significant association between the adjusted NRT and metabolic comorbidities or coronary disease (OR = 0.37, 95%CI = 0.13-1.01, <i>p</i> = 0.052). <b>Conclusions</b>: Overall, the NRT may be considered a predictive marker that is relative to the risk of exhibiting cardiovascular conditions.</p>","PeriodicalId":16722,"journal":{"name":"Journal of Personalized Medicine","volume":"14 12","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2024-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11677203/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Personalized Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jpm14121166","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The aim of this study was to determine whether the oral parameter reflecting the total number of remaining permanent teeth (NRT) on both arches represents a predictability factor for a certain type of cardiovascular condition. Methods: This study included 84 subjects (40 males and 44 females) with ages between 50 and 89 years old, hospitalized in the Cardiology Department, who required dental examinations and specialized therapeutic interventions within the Emergency Dental Department of the same medical facility. Results: The study participant's data were statically analyzed. An unadjusted oral parameter NRT < 21 may represent a statistically significant predictor of developing cardiomyopathy (OR = 8.00, 95%CI = 2.78-23.06, p < 0.0005), heart valve disease and arterial hypertension, in association with other comorbidities (except for metabolic or pulmonary comorbidities). The regression analyses revealed a borderline-significant association between the adjusted NRT and metabolic comorbidities or coronary disease (OR = 0.37, 95%CI = 0.13-1.01, p = 0.052). Conclusions: Overall, the NRT may be considered a predictive marker that is relative to the risk of exhibiting cardiovascular conditions.
期刊介绍:
Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.